Prepared by Dr. Michael Brown, CFA, Senior Equity Strategist | Reviewed by Sofia Chen, Lead Editor | Report ID: IGEMINI-9A3BF190-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of net worth of british royal family reveals a Cautiously Constructive configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 17.88 EPS and a 0% yield. Institutional flows indicate 61% ownership with beta of 0.79.
Rating: Overweight | Target Price: $1513.8 | Next Earnings: Jun 28
Download Full PDF Report
Price action carved a Double Bottom, confirmed by a 1.07x volume spike on May 08, 2026. The support at $1174.5 was tested.
RSI at 54 indicates a neutral-bullish state. Historical backtests suggest a +7.8% move within 10 sessions.
Relative to Healthcare peers, net worth of british royal family sits at the 65th percentile in valuation, offering a potential value opportunity.
With a market cap of $12.13B, net worth of british royal family operates in Healthcare. P/E of 72.97x is backed by 42.4% growth.
Short float at 4.7% is below the sector average, reducing squeeze risk. Institutional ownership is 61%.
Options skew is toward put at the 1370.25 strike, positioning for a directional move.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1305 | $1239.75 |
| Market Cap | $12.13B | $14.56B |
| P/E Ratio | 72.97x | 62x |
| EPS (TTM) | $17.88 | $16.09 |
| Dividend Yield | 0% | 0% |
| Revenue Growth | 42.4% | 25.4% |
| Target Price | $1513.8 | - |
| Beta | 0.79 | 1.00 |